This list is an analysis based on recent market events. It's not an investment recommendation.
C&R Research Inc. engages in the of clinical development for pharmaceuticals and medical devices. The company's therapeutic area comprises oncology, cardiovascular, endocrinology, dermatology, central nervous system, ophthalmology, and rare disease.The company was founded in 1997 and is based in Seoul, South Korea.
FAQs
What is C&R Research stock price today?▼
The current price of 359090.KQ is ₩1,985 KRW — it has decreased by -2.46% in the past 24 hours. Watch C&R Research stock price performance more closely on the chart.
What is C&R Research stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange C&R Research stocks are traded under the ticker 359090.KQ.
Is C&R Research stock price growing?▼
359090.KQ stock has fallen by -8.74% compared to the previous week, the month change is a -12.94% fall, over the last year C&R Research has showed a -55.99% decrease.
What is C&R Research market cap?▼
Today C&R Research has the market capitalization of 114.08B
What is C&R Research revenue for the last year?▼
C&R Research revenue for the last year amounts to 14.76B KRW.
What is C&R Research net income for the last year?▼
359090.KQ net income for the last year is -323.85M KRW.
Does C&R Research pay dividends?▼
Yes, 359090.KQ dividends are paid annual. The last dividend per share was 50 . As of today, Dividend Yield (FWD)% is 2.46%.
How many employees does C&R Research have?▼
As of November 3, 2026, the company has 482 employees.
In which sector is C&R Research located?▼
C&R Research operates in the Energy sector.
When did C&R Research complete a stock split?▼
The last stock split for C&R Research was on June 30, 2026 with a ratio of 1:5.
Where is C&R Research headquartered?▼
C&R Research is headquartered in Seoul, South Korea.